RaySearch receives 510(k) clearance for Pencil Beam

New Post Public Reply Private Reply Replies (0) Message Board

News Desk 2018

May 23, 2014 at 3:45 AM

RaySearch receives 510(k) clearance for Pencil Beam Scanning with protons

In December 2013 an extended version of RaySearch’s RayStation® 4.0 treatment planning system was CE-marked and released for clinical use to multiple markets. The new version contained tools for optimization of proton treatments using the pencil beam scanning technique (PBS). RaySearch has now received 510(k) clearance for this new version, which means that this new functionality can be sold and marketed in the US. Proton therapy is considered the most advanced form of radiation therapy due to its superior dose distribution and fewer side effects. Protons deposit the majority of their energy within a precisely controlled range, thus making it easier to target the tumor and to spare healthy surrounding tissue. PBS is the most sophisticated technique to deliver proton therapy. It enables Intensity Modulated Proton Therapy (IMPT) that allows clinicians to target a cancerous tumor by controlling both the intensity and the spatial distribution with millimeter precision. The proton module in RayStation® contains all the state-of-the-art tools needed for PBS such as multiple field optimization, single field uniform dose and distal edge tracking techniques. “We have won several orders and been the most successful supplier of solutions for proton treatment planning over the last year. Our position on the US market becomes even stronger now that we have market clearance for all relevant techniques for proton therapy”, says Johan Löf, CEO of RaySearch. About RayStation® RayStation® integrates all RaySearch’s advanced treatment planning solutions into a flexible treatment planning system. It combines unique features such as multi-criteria optimization tools with full support for 4D adaptive radiation therapy. It also includes functionality such as RaySearch’s market-leading algorithms for IMRT and VMAT optimization and highly accurate dose engines for photon, electron and proton therapy. The system is built on the latest software architecture and has a graphical user interface offering state-of-the-art usability. About RaySearch RaySearch Laboratories is a medical technology company that develops advanced software solutions for improved radiation therapy of cancer. RaySearch provides the RayStation® treatment planning system to clinics all over the world. In addition, RaySearch’s products are distributed through licensing agreements with leading partners such as Philips, Nucletron, IBA, Varian and Brainlab. To date, 15 products have been launched via partners and RaySearch’s software is used by over 2,500 clinics in more than 65 countries. RaySearch was founded in 2000 as a spin-off from the Karolinska Institute in Stockholm and the company is listed in the Small Cap segment on NASDAQ OMX Stockholm. For more information about RaySearch, visit www.raysearchlabs.com For further information, please contact: Johan Löf, President and CEO, RaySearch Laboratories AB (publ) Telephone: +46 (0)8-545 061 30 johan.lof@raysearchlabs.com

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

2026 Community Impact Week: Slam Dunk for Community Unity

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Duolingo Faces Lawsuit Over Alleged Investor Missteps

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Pacira BioSciences Faces Shareholder Revolt in M&A Deal

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

LEGO Mashes Star Wars and Marvel for Fans' Delight

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Top 5 Most Recently Viewed Articles

KPN Achieves Impressive Growth; Forecast for 2025 Enhanced

KPN Achieves Remarkable Growth in Q2 2025 KPN has recently demonstrated a strong performance in the second quarter of 2025, showcasing impressive growth across various segments. The company reported a year-on-year growth of 3.7% in service revenues, a testament to its robust business strategy and market position. Consumer Service Revenue Gains The consumer segment has...

Socket Mobile's Financial Trends Show Promise for Future Growth

Socket Mobile Reports Q3 Financial Results Socket Mobile, Inc. (NASDAQ: SCKT), a prominent name in the field of data capture and delivery solutions, recently disclosed its financial results for the third quarter of 2024, presenting notable shifts in revenue and product adoption. The company emphasizes its commitment to enhancing productivity through innovative...

Sapiens Recognized for Outstanding Software Solutions Excellence

Sapiens UnderwritingPro Achieves Recognition for Excellence Sapiens International Corporation has once again made waves in the insurance industry with its advanced UnderwritingPro solution. Renowned for driving efficiency and automation, the software provides comprehensive functionality that benefits insurers across various sectors. Honored with the XCelent Award...

Opportunity for LAZR Investors: Join the Class Action Today

Investing in Luminar Technologies: What You Need to Know For those invested in Luminar Technologies, Inc. (NASDAQ: LAZR), important news is unfolding regarding a recent class-action lawsuit that has potential implications for shareholders. The Rosen Law Firm, a reputable entity in securities law, has issued a reminder for investors who purchased Luminar securities during...

Celebrating HVAC Techs: Behind-the-Scenes Heroes

Recognizing the Unsung Heroes of Home Comfort Let's face it, HVAC techs don't always get the recognition they deserve. On National HVAC Technician Day, June 22, Bacon Plumbing Heating Air Electric took a moment to shine a light on those skilled folks keeping homes comfy year-round across the Dallas-Fort Worth Metroplex. You know, the folks who swoop in just in time during...